Fig. 2From: A novel stability-indicating method for determination of a new antidepressant effect of vortioxetine in a pharmaceutical formulation by using RP-HPLCChromatograms of (a) 20.0 μg mL−1, (b) 30.0 μg mL−1, (c) 40.0 μg mL−1, (d) 50.0 μg mL −1, (e) 60.0 μg mL−1, and (f) 70.0 μg mL−1, VRT, and 20.0 μg mL−1 internal standard CAF in mobile phaseBack to article page